Logo image of MGEN

Miragen Therapeutics Inc (MGEN) Stock News

NASDAQ:MGEN - Nasdaq -

23.01  -0.02 (-0.09%)

MGEN Latest News, Press Relases and Analysis

News Image
4 years ago - Benzinga

84 Biggest Movers From Yesterday

Gainers Zomedica Corp. (NYSE: ZOM) shares surged 92.2% to close at $0.93 on Monday after surging 21% on Friday. The company, last week, appointed Robert Cohen as Chief Executive...

Mentions: PI JUPW CGA EDIT ...

News Image
4 years ago - Benzinga

Why Miragen's Stock Is Trading Higher Today

Miragen Therapeutics (NASDAQ: MGEN) shares are trading higher on Wednesday after the company announced it is acquiring Viridian Therapeutics. No terms were disclosed. Miragen...

News Image
4 years ago - Zacks Investment Research

Arena (ARNA) Q3 Earnings Top, Stock Down on Eczema Study Data

Arena Pharmaceuticals (ARNA) beats bottom-line estimates for third-quarter 2020. Mid-stage atopic dermatitis study on etrasimod fails to meet primary endpoint but phase III study may start soon.

Mentions: ARNA EBS RGEN

News Image
4 years ago - InvestorPlace

Value-Added Acquisition Clears the Runway for Miragen Therapeutics

It was thrilling to watch MGEN stock spike, and the bull move might not be over as Miragen's new acquisition puts high-need medicine in focus.

News Image
4 years ago - Zacks Investment Research

Iovance (IOVA) Q3 Earnings Beat Estimates, Pipeline in Focus

Iovance's (IOVA) third-quarter earnings beat estimates. The company is progressing well with development of its lead pipeline candidate.

Mentions: MRK EBS IOVA

News Image
4 years ago - Zacks Investment Research

Sarepta (SRPT) Q3 Loss Widens Y/Y, Revenues Beat Estimates

Sarepta (SRPT) Q3 revenues increase year over year.

Mentions: BLRX SRPT EBS

News Image
4 years ago - Zacks Investment Research

Clovis (CLVS) Q3 Earnings Top, Sales Show Coronavirus Impact

Clovis (CLVS) reports mixed third-quarter 2020 results. Sales of the company's sole marketed drug, Rubraca, decline sequentially. Shares plunge.

Mentions: BMY EBS CLVS

News Image
4 years ago - Zacks Investment Research

Perrigo (PRGO) Q3 Earnings Beat, Revenues Miss, Stock Up

Perrigo (PRGO) reports decent third-quarter 2020 results. U.S. consumer self-care segment drives sales. Recovery in other two segments encouraging.

Mentions: BLRX PRGO EBS

News Image
4 years ago - PennyStocks.com

5 Biotech Penny Stocks To Watch Before Next Week; 1 Up Over 200%

Penny Stocks To Watch If Biotech Is Your Focus Right Now

Mentions: GTBP VTVT AMRN SESN

News Image
4 years ago - InvestorPlace

Miragen Therapeutics News: Why MGEN Stock Is Skyrocketing Today

Miragen Therapeutics news of its acquisition of Viridian Therapeutics has MGEN stock skyrocketing on Wednesday.